PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
39.61%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
-57.78%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
104.36%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
46.38%
Margin expansion exceeding 1.5x VET's 0.14%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
104.66%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
157.95%
Operating expenses growth above 1.5x VET's 18.33%. Michael Burry would check for inefficiency.
12.11%
Total costs growth above 1.5x VET's 5.18%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
4.52%
D&A growth while VET reduces D&A. John Neff would investigate differences.
53.25%
EBITDA growth while VET declines. John Neff would investigate advantages.
319.57%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
79.08%
Operating income growth while VET declines. John Neff would investigate advantages.
28.27%
Operating margin growth while VET declines. John Neff would investigate advantages.
-109.18%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-17.34%
Both companies show declining income. Martin Whitman would check industry conditions.
-40.80%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-6.50%
Tax expense reduction while VET shows 48.56% growth. Joel Greenblatt would examine advantage.
-37.63%
Both companies show declining income. Martin Whitman would check industry conditions.
-55.33%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-26.99%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-28.67%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-0.33%
Share count reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.
1.66%
Diluted share change of 1.66% while VET is stable. Bruce Berkowitz would verify approach.